| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP8B3 ERCC6 LONP2 MCM7 CHD2 CHD7 DNAH7 ATP8B2 ABCA8 SLFN13 DDX20 SLFN11 DNAH6 | 4.75e-05 | 441 | 157 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP8B3 SETX ERCC6 LONP2 MCM7 CHD2 CHD7 DNAH7 ATP8B2 ABCA8 DNAH1 SLFN13 DDX20 SLFN11 DNAH6 | 1.04e-04 | 614 | 157 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | helicase activity | 2.57e-04 | 158 | 157 | 7 | GO:0004386 | |
| GeneOntologyCellularComponent | inner dynein arm | 4.89e-05 | 10 | 158 | 3 | GO:0036156 | |
| Domain | TF_fork_head_CS_2 | 3.73e-05 | 46 | 154 | 5 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 4.14e-05 | 47 | 154 | 5 | IPR018122 | |
| Domain | FH | 5.08e-05 | 49 | 154 | 5 | SM00339 | |
| Domain | FORK_HEAD_1 | 5.08e-05 | 49 | 154 | 5 | PS00657 | |
| Domain | FORK_HEAD_2 | 5.08e-05 | 49 | 154 | 5 | PS00658 | |
| Domain | Fork_head_dom | 5.08e-05 | 49 | 154 | 5 | IPR001766 | |
| Domain | FORK_HEAD_3 | 5.08e-05 | 49 | 154 | 5 | PS50039 | |
| Domain | Forkhead | 5.08e-05 | 49 | 154 | 5 | PF00250 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.87e-04 | 14 | 154 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.87e-04 | 14 | 154 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.87e-04 | 14 | 154 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.87e-04 | 14 | 154 | 3 | PF08393 | |
| Domain | MT | 1.87e-04 | 14 | 154 | 3 | PF12777 | |
| Domain | AAA_8 | 1.87e-04 | 14 | 154 | 3 | PF12780 | |
| Domain | DUF2075 | 2.02e-04 | 3 | 154 | 2 | PF09848 | |
| Domain | DUF2075 | 2.02e-04 | 3 | 154 | 2 | IPR018647 | |
| Domain | P-loop_NTPase | TANC2 SETX ERCC6 LONP2 MCM7 CHD2 CHD7 GAL3ST2 DNAH7 ABCA8 DNAH1 NWD2 SLFN13 YLPM1 DDX20 SLFN11 DNAH6 MYO16 | 2.22e-04 | 848 | 154 | 18 | IPR027417 |
| Domain | DHC_fam | 2.33e-04 | 15 | 154 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.33e-04 | 15 | 154 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.33e-04 | 15 | 154 | 3 | IPR004273 | |
| Domain | PTCB-BRCT | 4.01e-04 | 4 | 154 | 2 | PF12738 | |
| Domain | TF_AF4/FMR2 | 4.01e-04 | 4 | 154 | 2 | IPR007797 | |
| Domain | AF-4 | 4.01e-04 | 4 | 154 | 2 | PF05110 | |
| Domain | EGF | 6.23e-04 | 126 | 154 | 6 | PF00008 | |
| Domain | FN3 | 8.73e-04 | 185 | 154 | 7 | SM00060 | |
| Domain | Na_trans_cytopl | 9.91e-04 | 6 | 154 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 9.91e-04 | 6 | 154 | 2 | IPR024583 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | USP36 PHLDB3 SETX ERCC6 RPAP3 POLA1 FERMT1 BAZ1B MCM7 CHD2 CHD7 EPB41L3 NCAPH ECT2 STAU1 SLC25A3 RPTOR DDX20 PLCG2 WDFY3 SNRPA PLOD1 MED12 | 6.86e-08 | 1353 | 160 | 23 | 29467282 |
| Pubmed | USP36 TET2 USP34 KIFBP SETX JADE3 VPS13C TOPBP1 ANKLE2 NCAPH RPTOR ADGRL2 ACAP2 CNOT1 | 1.81e-07 | 529 | 160 | 14 | 14621295 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | USP34 RBBP6 BAZ1B MCM7 CHD2 YY1 ITGB5 NSDHL SLC25A3 LSR PTPRF RPTOR NUP210 GHITM ARID5B ITPRIP ATF4 PLOD1 CNOT1 MED12 | 7.51e-07 | 1203 | 160 | 20 | 29180619 |
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 39056782 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF793 TCHP VPS13C KIAA0232 DYNC2I1 XIAP CHD2 SPPL2B ITGB5 SFMBT2 NBPF1 DNAH1 CAMK2N1 GRTP1 RPTOR NUP210 ARID5B IFT122 PLOD1 CNOT1 TSEN15 AFF4 | 1.43e-06 | 1489 | 160 | 22 | 28611215 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CFAP47 SETX POLA1 VPS13C EVPL CHD2 GAL3ST2 ECT2 PTGS1 ESRP2 SCN3A ARID5B MMP2 CNOT1 CDK5R2 | 1.75e-06 | 736 | 160 | 15 | 29676528 |
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 29073098 | ||
| Pubmed | USP36 USP34 SETX AFF2 VPS13C FERMT1 MUC16 MCM7 EPB41L3 NCAPH DNAH7 LSR SLFN13 ADGRL2 TASOR | 3.38e-06 | 777 | 160 | 15 | 35844135 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 SETX TCHP RBBP6 TOPBP1 BAZ1B MCM7 CHD7 PIK3C2B RPTOR ARID5B DDX20 SLFN11 | 3.68e-06 | 588 | 160 | 13 | 38580884 |
| Pubmed | TET2 USP34 RPAP3 MCM7 CHD7 EPB41L3 SFMBT2 ARID5B TASOR CNOT1 MED12 | 4.15e-06 | 418 | 160 | 11 | 34709266 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | USP36 SETX RBBP6 TOPBP1 BAZ1B CHD7 EPB41L3 YY1 STAU1 SLC25A3 BRD2 YLPM1 SNRPA TASOR ALK AFF4 | 9.27e-06 | 954 | 160 | 16 | 36373674 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SETX RBBP6 PDK1 CHD2 CHD7 EPB41L3 STAU1 NSDHL SLC25A3 NWD2 BRD2 YLPM1 SNRPA PLOD1 CNOT1 MED12 AFF4 | 1.12e-05 | 1082 | 160 | 17 | 38697112 |
| Pubmed | USP34 POLA1 BAZ1B CHD2 CHD7 EPB41L3 STAU1 NUP210 YLPM1 DDX20 PLOD1 CNOT1 MED12 | 1.13e-05 | 653 | 160 | 13 | 22586326 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 TET2 SETX MATK KIAA0232 XIAP EPB41L3 ECT2 DNAH7 RUSC2 LSR PIK3C2B RPTOR SVIL MAP3K2 | 1.15e-05 | 861 | 160 | 15 | 36931259 |
| Pubmed | USP34 SETX BAZ1B XIAP CHD2 CHD7 FCHO2 RPP14 SPPL2B ANKLE2 NFE2L1 ARID5B ITPRIP ACCSL TASOR CNOT1 AFF4 | 1.15e-05 | 1084 | 160 | 17 | 11544199 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TANC2 PHLDB3 KIFBP TCHP RPAP3 LONP2 DYNC2I1 XIAP MCM7 ANKLE2 ECT2 NSDHL RPTOR DDX20 IFT122 FUCA1 ACAP2 CNOT1 MAP3K2 | 1.15e-05 | 1321 | 160 | 19 | 27173435 |
| Pubmed | USP36 TANC2 USP34 ERCC6 FOXP2 RBBP6 BAZ1B XIAP EPB41L3 YY1 ABCA8 BRD2 RPTOR SLFN11 WDFY3 ADGRL2 AFF4 | 1.67e-05 | 1116 | 160 | 17 | 31753913 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TANC2 KIFBP SETX FERMT1 CHD7 EPB41L3 NCAPH ECT2 BRD2 YLPM1 SNRPA CNOT1 | 1.76e-05 | 582 | 160 | 12 | 20467437 |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20346423 | ||
| Pubmed | The human language-associated gene SRPX2 regulates synapse formation and vocalization in mice. | 2.10e-05 | 2 | 160 | 2 | 24179158 | |
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 2.10e-05 | 2 | 160 | 2 | 11245985 | |
| Pubmed | TASOR epigenetic repressor cooperates with a CNOT1 RNA degradation pathway to repress HIV. | 2.10e-05 | 2 | 160 | 2 | 35013187 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 2.10e-05 | 2 | 160 | 2 | 23016767 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27153334 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 7665159 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 11355014 | ||
| Pubmed | Cleavage of human corneal type VI collagen alpha 3 chain by matrix metalloproteinase-2. | 2.10e-05 | 2 | 160 | 2 | 8862926 | |
| Pubmed | The PcG gene Sfmbt2 is paternally expressed in extraembryonic tissues. | 2.10e-05 | 2 | 160 | 2 | 18024232 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 26067486 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 32083332 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 37833372 | ||
| Pubmed | FYN-TRAF3IP2 induces NF-κB signaling-driven peripheral T cell lymphoma. | 2.10e-05 | 2 | 160 | 2 | 33928261 | |
| Pubmed | Deleterious variants in X-linked CFAP47 induce asthenoteratozoospermia and primary male infertility. | 2.10e-05 | 2 | 160 | 2 | 33472045 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 29563550 | ||
| Pubmed | 2.11e-05 | 72 | 160 | 5 | 33726789 | ||
| Pubmed | SETX ERCC6 RBBP6 TOPBP1 FCHO2 EPB41L3 ANKLE2 NCAPH ECT2 RPTOR DDX20 | 2.33e-05 | 503 | 160 | 11 | 16964243 | |
| Pubmed | 3.10e-05 | 191 | 160 | 7 | 31177093 | ||
| Pubmed | 3.35e-05 | 14 | 160 | 3 | 9373155 | ||
| Pubmed | PHLDB3 USP34 RPAP3 VPS13C DYNC2I1 CHD7 YY1 STAU1 NSDHL HGS YLPM1 DDX20 TASOR | 3.75e-05 | 733 | 160 | 13 | 34672954 | |
| Pubmed | 5.12e-05 | 16 | 160 | 3 | 16376864 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 DOCK3 PHLDB3 USP34 SPPL2B ITGB5 NBPF1 ESRP2 BRD2 GRTP1 PTPRF CELSR2 PIK3C2B RPTOR WDFY3 MED12 | 5.46e-05 | 1105 | 160 | 16 | 35748872 |
| Pubmed | 5.66e-05 | 210 | 160 | 7 | 16565220 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 19284629 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 23859570 | ||
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 6.29e-05 | 3 | 160 | 2 | 31985401 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 20139422 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 6.29e-05 | 3 | 160 | 2 | 33656439 | |
| Pubmed | G-quadruplexes in the BAP1 promoter positively regulate its expression. | 6.29e-05 | 3 | 160 | 2 | 29787736 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 29884702 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 30905672 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 38875319 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 26916087 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 12610651 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 29913136 | ||
| Pubmed | Regulation of DU145 prostate cancer cell growth by Scm-like with four mbt domains 2. | 6.29e-05 | 3 | 160 | 2 | 23385818 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 10518787 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 25703008 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 18784617 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 9784606 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 17544618 | ||
| Pubmed | A role for TSLP in the development of inflammation in an asthma model. | 6.29e-05 | 3 | 160 | 2 | 16172260 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 22504639 | ||
| Pubmed | Molecular networks implicated in speech-related disorders: FOXP2 regulates the SRPX2/uPAR complex. | 6.29e-05 | 3 | 160 | 2 | 20858596 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 16052353 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 21330300 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 30277262 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 14973256 | ||
| Pubmed | 6.80e-05 | 469 | 160 | 10 | 27634302 | ||
| Pubmed | USP36 RPAP3 FCHO2 ANKLE2 PTPRD BRD2 PTPRF SVIL NUP210 HGS YLPM1 SLFN11 ADGRL2 PLOD1 CNOT1 | 1.08e-04 | 1049 | 160 | 15 | 27880917 | |
| Pubmed | 1.13e-04 | 102 | 160 | 5 | 10231032 | ||
| Pubmed | Functional genomics identifies therapeutic targets for MYC-driven cancer. | 1.18e-04 | 103 | 160 | 5 | 22623531 | |
| Pubmed | A structural hierarchy mediated by multiple nuclear factors establishes IgH locus conformation. | 1.25e-04 | 4 | 160 | 2 | 26302788 | |
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 17537961 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 22292071 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 35908044 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 8524829 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 35142046 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 35801810 | ||
| Pubmed | Contractile activity-induced mitochondrial biogenesis and mTORC1. | 1.25e-04 | 4 | 160 | 2 | 22700793 | |
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 12695546 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 35031483 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 35443168 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 22659470 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 29578003 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 35705052 | ||
| Pubmed | Epithelial cell-derived cytokine TSLP activates regulatory T cells by enhancing fatty acid uptake. | 1.25e-04 | 4 | 160 | 2 | 36717741 | |
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 31541101 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 12880872 | ||
| Pubmed | Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice. | 1.25e-04 | 4 | 160 | 2 | 11923441 | |
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 18761086 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 16397239 | ||
| Pubmed | Mediation of Af4 protein function in the cerebellum by Siah proteins. | 1.25e-04 | 4 | 160 | 2 | 15459319 | |
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 1.25e-04 | 4 | 160 | 2 | 8974318 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.26e-04 | 608 | 160 | 11 | 36089195 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 1.27e-04 | 410 | 160 | 9 | 26949251 | |
| Pubmed | 1.38e-04 | 169 | 160 | 6 | 31462741 | ||
| Pubmed | 1.55e-04 | 421 | 160 | 9 | 36976175 | ||
| Pubmed | TANC2 KIFBP FOXP2 CHD7 EPB41L3 PTPRD CELSR2 RPTOR SVIL YLPM1 RIMBP2 WDFY3 CNOT1 AFF4 | 1.56e-04 | 963 | 160 | 14 | 28671696 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | JADE3 RPAP3 VPS13C KIAA0232 DYNC2I1 XIAP FCHO2 ANKLE2 DNAH7 SVIL HGS PLOD1 CNOT1 | 1.70e-04 | 853 | 160 | 13 | 28718761 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | KIFBP SETX FOXP2 NPAS3 NCAPH ECT2 YY1 TTLL7 NSDHL ESRP2 FOXB1 ADGRL2 FOXI1 | 1.78e-04 | 857 | 160 | 13 | 25609649 |
| GeneFamily | Forkhead boxes | 8.24e-06 | 43 | 117 | 5 | 508 | |
| GeneFamily | Dyneins, axonemal | 1.68e-04 | 17 | 117 | 3 | 536 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 2.47e-04 | 4 | 117 | 2 | 1145 | |
| GeneFamily | Schlafen family | 8.54e-04 | 7 | 117 | 2 | 1110 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.16e-03 | 181 | 117 | 6 | 694 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.45e-03 | 9 | 117 | 2 | 1280 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.45e-03 | 9 | 117 | 2 | 1203 | |
| GeneFamily | Fibronectin type III domain containing | 3.86e-03 | 160 | 117 | 5 | 555 | |
| GeneFamily | ATPase phospholipid transporting | 4.13e-03 | 15 | 117 | 2 | 1210 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | DOCK3 FAM163A DPP10 SYT6 FOXB2 NPAS3 EPB41L3 CORO2B AEBP1 MYO16 ALOX15 FOXE3 | 1.69e-05 | 438 | 160 | 12 | M1954 |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | DOCK3 FAM163A DPP10 SYT6 FOXB2 NPAS3 EPB41L3 CORO2B AEBP1 MYO16 ALOX15 FOXE3 | 1.77e-05 | 440 | 160 | 12 | MM832 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 2.44e-05 | 250 | 160 | 9 | M11318 | |
| Coexpression | GSE14308_TH2_VS_TH17_UP | 3.31e-05 | 200 | 160 | 8 | M3361 | |
| Coexpression | GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP | 3.31e-05 | 200 | 160 | 8 | M5476 | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.86e-07 | 179 | 160 | 8 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 3.25e-07 | 182 | 160 | 8 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.50e-07 | 190 | 160 | 8 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.68e-07 | 191 | 160 | 8 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-07 | 192 | 160 | 8 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 4.87e-07 | 192 | 160 | 8 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-07 | 192 | 160 | 8 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.27e-07 | 194 | 160 | 8 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | background-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.48e-07 | 195 | 160 | 8 | c7d60dabfc7cb310e002cab10003dadfcc34fe33 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.70e-07 | 196 | 160 | 8 | 4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.70e-07 | 196 | 160 | 8 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.92e-07 | 197 | 160 | 8 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.92e-07 | 197 | 160 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.92e-07 | 197 | 160 | 8 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.15e-07 | 198 | 160 | 8 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.02e-06 | 162 | 160 | 7 | 6ffcf369d954c20ce036aa1d072cee4e205f728e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.02e-06 | 162 | 160 | 7 | bcbf7f80a2a1c80def795e345f16cf16e8b9d03b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.29e-06 | 165 | 160 | 7 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.29e-06 | 165 | 160 | 7 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | critical-Myeloid-Mast_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.29e-06 | 165 | 160 | 7 | 34a1cc6ccd46c059354e8fbde1ac69f202695a4e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-06 | 166 | 160 | 7 | 9d4b44eb56ad38c26aed73444edf389abca6bdf6 | |
| ToppCell | 10x5'-lymph-node_spleen-Mast-Mast_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 2.58e-06 | 168 | 160 | 7 | 650ad3ea52577887885d82457dbc04202ce3eb34 | |
| ToppCell | 10x5'-lymph-node_spleen-Mast|lymph-node_spleen / Manually curated celltypes from each tissue | 2.58e-06 | 168 | 160 | 7 | e58ffbb57c81967766755c3f6f347b158a39cb0d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-06 | 169 | 160 | 7 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-06 | 170 | 160 | 7 | a121e10099faaeb60251eec162f38caf7c4238c2 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-06 | 175 | 160 | 7 | f7cd2ef79d91d64976fcdb5f1e7343b24ba27456 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.07e-06 | 180 | 160 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.37e-06 | 182 | 160 | 7 | d7cce5dd7046f06bf40f00c9dbfa610722b03333 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.87e-06 | 185 | 160 | 7 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.04e-06 | 186 | 160 | 7 | 0cc7504297fd0c97ea50e4b3ff58fcedc4c1cfaa | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.04e-06 | 186 | 160 | 7 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.04e-06 | 186 | 160 | 7 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.04e-06 | 186 | 160 | 7 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | 10x5'-Lung-Mast|Lung / Manually curated celltypes from each tissue | 5.23e-06 | 187 | 160 | 7 | f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0 | |
| ToppCell | 10x5'-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue | 5.23e-06 | 187 | 160 | 7 | da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 5.23e-06 | 187 | 160 | 7 | be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.41e-06 | 188 | 160 | 7 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.60e-06 | 189 | 160 | 7 | aba941ba6ce7702418b3f470bde573d123c4aade | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.60e-06 | 189 | 160 | 7 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.60e-06 | 189 | 160 | 7 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-06 | 189 | 160 | 7 | dde037322c8caec0c04c5be1c1b59a167824ad9f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.60e-06 | 189 | 160 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.60e-06 | 189 | 160 | 7 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.80e-06 | 190 | 160 | 7 | 40d8b3403f4e38436b961cd3a2e69826cbae3042 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.80e-06 | 190 | 160 | 7 | f6cbf6d292f488ada5f7581e1dceba6198b933d1 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.80e-06 | 190 | 160 | 7 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.80e-06 | 190 | 160 | 7 | a9a705455019e28d655636de73b07540798f82e6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.80e-06 | 190 | 160 | 7 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.80e-06 | 190 | 160 | 7 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.80e-06 | 190 | 160 | 7 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.00e-06 | 191 | 160 | 7 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.00e-06 | 191 | 160 | 7 | 36467322096bc766cd777dae3bfb4e65511e492c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.00e-06 | 191 | 160 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.00e-06 | 191 | 160 | 7 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.00e-06 | 191 | 160 | 7 | 94795daf05061baa3b72a1b01c9e940af86de044 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.00e-06 | 191 | 160 | 7 | cd497abed9e00e4e0becd9dbc036c6e7a60ae791 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.00e-06 | 191 | 160 | 7 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.00e-06 | 191 | 160 | 7 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.00e-06 | 191 | 160 | 7 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class (2021.01.30) | 6.00e-06 | 191 | 160 | 7 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.21e-06 | 192 | 160 | 7 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.21e-06 | 192 | 160 | 7 | 690cf19e9b0b2ada80097c63eae827529aa5b6f3 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.21e-06 | 192 | 160 | 7 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.21e-06 | 192 | 160 | 7 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.21e-06 | 192 | 160 | 7 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.21e-06 | 192 | 160 | 7 | 3d6c4c5847ca1e44fa380403d25af45d5b51ee9b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.21e-06 | 192 | 160 | 7 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.21e-06 | 192 | 160 | 7 | e0412964a3ee1bf3c0ef64f9a6f20f7e7835701e | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 6.21e-06 | 192 | 160 | 7 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.21e-06 | 192 | 160 | 7 | b5871247a5f3e970fa05b33fff21bef9d2ab5741 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.43e-06 | 193 | 160 | 7 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.43e-06 | 193 | 160 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.43e-06 | 193 | 160 | 7 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-06 | 193 | 160 | 7 | 1f978e102a029a6beb10913052cd0a20c7253e8e | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.43e-06 | 193 | 160 | 7 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.65e-06 | 194 | 160 | 7 | d024cd75a97f048257e49cee9190fb2e79202ee2 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-06 | 194 | 160 | 7 | ce32e60bcea1b8baf496ce9050832bc8c77d8434 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-06 | 194 | 160 | 7 | a1dc157148885cc8d3685ac81a1f4e3562aeecc9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.65e-06 | 194 | 160 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.65e-06 | 194 | 160 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.65e-06 | 194 | 160 | 7 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 6.65e-06 | 194 | 160 | 7 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.87e-06 | 195 | 160 | 7 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.87e-06 | 195 | 160 | 7 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.87e-06 | 195 | 160 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.87e-06 | 195 | 160 | 7 | 5870b2956d50d6550a3174a220a6cc70c5538d70 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-06 | 195 | 160 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 7.11e-06 | 196 | 160 | 7 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.11e-06 | 196 | 160 | 7 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 7.11e-06 | 196 | 160 | 7 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.11e-06 | 196 | 160 | 7 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-06 | 196 | 160 | 7 | 4cd1e6b7a791e11a40b19f971b7011bd11fe6273 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-06 | 196 | 160 | 7 | fcb275746bf51269ed8ba4cf93edb054a45f1ccd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-06 | 196 | 160 | 7 | d37f714d4fb57e958f3738fdda085560813e5bb5 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.35e-06 | 197 | 160 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.35e-06 | 197 | 160 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.35e-06 | 197 | 160 | 7 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.35e-06 | 197 | 160 | 7 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.35e-06 | 197 | 160 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.35e-06 | 197 | 160 | 7 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| Disease | eosinophil count | DOCK3 TET2 KIFBP IP6K3 TCHP KIAA0232 FERMT1 CHD7 ANKLE2 NCAPH DNAH7 CRLF2 PIK3C2B FUCA1 NOSTRIN FER1L5 PLOD1 MYO16 ALOX15 NOTCH4 | 1.09e-04 | 1488 | 155 | 20 | EFO_0004842 |
| Disease | opioid dependence | 2.68e-04 | 237 | 155 | 7 | EFO_0005611 | |
| Disease | platelet measurement | 2.73e-04 | 315 | 155 | 8 | EFO_0005036 | |
| Disease | conotruncal heart malformations | 3.47e-04 | 114 | 155 | 5 | MONDO_0016581 | |
| Disease | pappalysin-1 measurement | 4.06e-04 | 6 | 155 | 2 | EFO_0802845 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 5.41e-04 | 71 | 155 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | cancer (implicated_via_orthology) | 5.60e-04 | 268 | 155 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 5.66e-04 | 7 | 155 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | response to aromatase inhibitor | 6.31e-04 | 32 | 155 | 3 | GO_0061477 | |
| Disease | Alzheimer disease, language impairment | 9.63e-04 | 9 | 155 | 2 | EFO_0005425, MONDO_0004975 | |
| Disease | Glaucoma | 9.63e-04 | 9 | 155 | 2 | C0017601 | |
| Disease | mean platelet volume | TET2 POLA1 KIAA0232 DYNC2I1 CHD7 FCHO2 SRPX2 GRTP1 NFE2L1 SVIL ITPRIP PLCG2 ACAP2 TASOR | 1.01e-03 | 1020 | 155 | 14 | EFO_0004584 |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.20e-03 | 10 | 155 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.20e-03 | 10 | 155 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | cancer antigen 125 measurement | 1.20e-03 | 10 | 155 | 2 | EFO_0010603 | |
| Disease | diet measurement | IP6K3 FOXP2 NPAS3 BAZ1B CHD2 NWD2 PTPRF CELSR2 NFE2L1 SCN2A PLCG2 ADGRL2 CNOT1 MYO16 | 1.32e-03 | 1049 | 155 | 14 | EFO_0008111 |
| Disease | campesterol measurement | 1.46e-03 | 11 | 155 | 2 | EFO_0020008 | |
| Disease | colorectal cancer (is_marker_for) | 1.47e-03 | 157 | 155 | 5 | DOID:9256 (is_marker_for) | |
| Disease | Neurodevelopmental Disorders | 1.49e-03 | 93 | 155 | 4 | C1535926 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.75e-03 | 12 | 155 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Alzheimer disease, educational attainment | 2.00e-03 | 247 | 155 | 6 | EFO_0011015, MONDO_0004975 | |
| Disease | skin melanoma (is_marker_for) | 2.06e-03 | 13 | 155 | 2 | DOID:8923 (is_marker_for) | |
| Disease | unipolar depression, mood disorder, response to antidepressant | 2.39e-03 | 14 | 155 | 2 | EFO_0003761, EFO_0004247, GO_0036276 | |
| Disease | colonic neoplasm, overall survival | 2.39e-03 | 14 | 155 | 2 | EFO_0000638, EFO_0004288 | |
| Disease | insomnia measurement | 2.45e-03 | 443 | 155 | 8 | EFO_0007876 | |
| Disease | Schizophrenia | FOXP2 CYP3A4 NPAS3 PTGS1 CNIH3 CFAP65 PLA2G4C ATF4 ALK MED12 MYO16 NOTCH4 | 2.51e-03 | 883 | 155 | 12 | C0036341 |
| Disease | 3-hydroxy-1-methylpropylmercapturic acid measurement | 2.67e-03 | 352 | 155 | 7 | EFO_0007015 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.75e-03 | 53 | 155 | 3 | C4707243 | |
| Disease | 1,3,7-trimethylurate measurement | 2.75e-03 | 15 | 155 | 2 | EFO_0021172 | |
| Disease | phosphorus measurement | 3.13e-03 | 16 | 155 | 2 | EFO_0004861 | |
| Disease | amino acid measurement | TANC2 GABRG3 SETX DNAH7 MMRN1 BRINP2 ADGRL2 ALK MYO16 ALOX15 | 3.21e-03 | 678 | 155 | 10 | EFO_0005134 |
| Disease | ocular hypertension (biomarker_via_orthology) | 3.54e-03 | 17 | 155 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | protein C measurement | 3.54e-03 | 17 | 155 | 2 | EFO_0004633 | |
| Disease | major depressive disorder (is_implicated_in) | 3.54e-03 | 17 | 155 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | immature platelet measurement | 3.64e-03 | 119 | 155 | 4 | EFO_0803541 | |
| Disease | health study participation | 3.76e-03 | 195 | 155 | 5 | EFO_0010130 | |
| Disease | attention deficit hyperactivity disorder, Cannabis use | 3.97e-03 | 18 | 155 | 2 | EFO_0003888, EFO_0007585 | |
| Disease | age at menarche | 4.29e-03 | 594 | 155 | 9 | EFO_0004703 | |
| Disease | serum metabolite measurement | TANC2 GABRG3 CYP3A4 TMEM233 SYT6 GUSBP1 NWD2 CELSR2 GHITM ARID5B PLCG2 ALK | 4.31e-03 | 945 | 155 | 12 | EFO_0005653 |
| Disease | metabolonic lactone sulfate measurement | 4.42e-03 | 19 | 155 | 2 | EFO_0800659 | |
| Disease | Omenn Syndrome | 4.42e-03 | 19 | 155 | 2 | C2700553 | |
| Disease | C-reactive protein measurement | DOCK3 USP34 ZNF793 CYP3A4 VPS13C TMEM233 BAZ1B CHD7 ATP8B2 GRTP1 PTPRF CELSR2 DDX20 AFF4 | 4.64e-03 | 1206 | 155 | 14 | EFO_0004458 |
| Disease | exercise test | 4.90e-03 | 20 | 155 | 2 | EFO_0004328 | |
| Disease | cerebellum white matter volume change measurement, age at assessment | 4.90e-03 | 20 | 155 | 2 | EFO_0008007, EFO_0021498 | |
| Disease | attention deficit hyperactivity disorder (is_implicated_in) | 4.90e-03 | 20 | 155 | 2 | DOID:1094 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLGDIYSPDSLMKYL | 331 | Q4AC99 | |
| PAESVPLIGKYYMAT | 291 | Q9GZZ6 | |
| DLYLNTPDKMGYDTP | 401 | Q86XL3 | |
| LPKNGSYRPSYEEML | 26 | Q8NC06 | |
| ERLVSYPYDMARTPT | 766 | Q8IUX7 | |
| FLLDPYKYMTLNPST | 291 | Q9UIG0 | |
| DPLEAKSPYTMYSET | 1116 | P51816 | |
| GDRKPDYTAYVAMIP | 191 | P18848 | |
| LRVDYKYNPEAMVAP | 686 | Q0JRZ9 | |
| GLYSKTMTPIYDPIN | 181 | Q9BQL6 | |
| PSRRSENEDIYYKSM | 1396 | O95490 | |
| MYYKPQDVPAKARST | 466 | O60423 | |
| QYVLRAYAVDKGMPP | 886 | Q9HCU4 | |
| YPEFLANALTKYMRD | 246 | Q9UHI6 | |
| YRASYEKNLPKMAEA | 611 | Q15057 | |
| YTVDMPSYVPKNADV | 2601 | Q9P2D1 | |
| SYMGNEISYPLKPFL | 271 | Q13319 | |
| LELMPPDSFKSREYY | 306 | Q8N608 | |
| PFPMYSETVDLIKYT | 966 | Q9UHB7 | |
| DVPEQRSMEYPKLYE | 946 | P98198 | |
| RSMEYPKLYEPGQLN | 951 | P98198 | |
| PTITSMRRDAYYFDP | 51 | Q5T5A4 | |
| NSVPAAYYLRPKSEM | 166 | Q9ULI1 | |
| YRIINYPHDMKPSAV | 106 | Q9NRE1 | |
| DPGALMAPIYTYTKN | 416 | P08253 | |
| PEYSKFCRMSYQDPA | 546 | Q14494 | |
| VPFYSTELNKPAMIY | 431 | P55895 | |
| RAGETMYLYEKANTP | 346 | Q9H8V3 | |
| YEMLKNAPALISEYS | 521 | Q8IWB1 | |
| LFNYMYSTAPRPRVE | 331 | Q15118 | |
| SNYPMVNSVFIPRKY | 571 | Q6ZRR7 | |
| GDEDYYKQRLSPKMP | 456 | P0DP91 | |
| TYIPPSYISEMEKAA | 186 | Q8TEM1 | |
| VKTYERLFYMVAPSP | 606 | Q6NSJ2 | |
| PSITKDMDLYSYRLP | 161 | Q02252 | |
| RYASESMSYPDPSKA | 2986 | Q8WXI7 | |
| GMYFRPLTSYSPKDA | 256 | Q9Y585 | |
| DQKPPYSYISLTAMA | 11 | Q5VYV0 | |
| YANTLRDAAPKMYKE | 196 | Q00325 | |
| PQSAPMYQYLDRKLF | 616 | Q9HBG6 | |
| PQSMPEYALTRNYLE | 301 | Q86WA8 | |
| EVFSYGRAPYPKMSL | 416 | P42679 | |
| RAEVSPMYGVQKYDP | 301 | Q9H3K2 | |
| VNPYKELPIYSSMVS | 441 | Q9Y6X6 | |
| LAPDFSKGSYRYAPM | 1086 | Q13201 | |
| PQYLKEVSMYSREEP | 861 | Q6ZU64 | |
| RDYDLMKANEPGTSY | 61 | O14990 | |
| PPVNEYDMYIRNFGK | 511 | Q8WVS4 | |
| NKAPPTYDTVLQMEY | 341 | P08684 | |
| YYDTSNKIMEPHRPN | 6 | Q6ZQW0 | |
| AELSPPAKDQVEMYY | 161 | Q92628 | |
| LYRSDSDYELSPKAM | 121 | Q08493 | |
| AEYRALYEKMVLPPD | 131 | Q92817 | |
| PETGKDMSPYEAYKR | 1691 | Q92817 | |
| DKYNIPMSSEIAPNY | 481 | O15409 | |
| TMPELYDLVNSYKPD | 211 | P04066 | |
| GESYPKSRMPRAQSY | 226 | Q9Y2U5 | |
| MRDPKPTYPYTQETT | 271 | Q99972 | |
| NAKLDMPYEYLRPSV | 641 | P16050 | |
| PERPNGVILDYEMKY | 476 | P54753 | |
| EQLQKMAEYYRPGPA | 196 | Q93074 | |
| NPSMPQRTVKALYDY | 766 | P16885 | |
| YVLQPESMRTEKYDP | 1036 | P16885 | |
| LKYQVLDGEMYPPSV | 251 | P23219 | |
| RVKAMEDVYGPDTYP | 186 | Q9HC73 | |
| YEMASNPLYRKPIST | 766 | P18084 | |
| YESLPLAMKRFTPQY | 51 | Q96PC2 | |
| IPPEMLASYKSYSGT | 841 | Q3BBV0 | |
| EYLEVKYSAEMPQLP | 451 | P09884 | |
| PMVPESLADYITAAY | 571 | P33993 | |
| FNRYREVPPPYDMKA | 796 | Q7Z6E9 | |
| APMTEKLYPGYYTRA | 621 | Q02809 | |
| DQKPPYSYISLTAMA | 11 | Q99853 | |
| NPTYNEMLVYDGIPK | 1566 | O00750 | |
| DYINGDSKYMRPPSK | 286 | Q9NR21 | |
| DSKYMRPPSKDGSYV | 291 | Q9NR21 | |
| ELMNVAGLYYPKDSA | 521 | Q9UP65 | |
| YMARLYALQFPEKPL | 376 | Q9H3Q3 | |
| YLSYIKSLPLNDMPE | 3931 | Q9P2D7 | |
| ASLSEIDPMYQYSLK | 3306 | Q9C0G6 | |
| SAKVDPPEYMLELYN | 76 | O95393 | |
| YLSYLMEFRSPAPQK | 306 | Q9UQ03 | |
| YRDRPSSAMYPAAIL | 1786 | Q8IZD9 | |
| PLIFSSYGYPKEEMI | 186 | Q99928 | |
| PNNMSRKRPYDQYSS | 1691 | O14647 | |
| LDLPKAERPRFYTMY | 306 | O14638 | |
| LPDYYSPAMLGLKTD | 186 | Q5TC63 | |
| YIAYLVRQLDMSPDP | 2641 | P12111 | |
| SLHEYDKDNIPPAYM | 2751 | Q8WXX0 | |
| YSSPFYIRTADMVPN | 101 | Q96GL9 | |
| EELMKLVRPPYSYSA | 116 | Q12951 | |
| MDRSNPVKPALDYFS | 1 | Q15486 | |
| LEAAVSPMDYPASYS | 526 | Q68D06 | |
| FINMYTRPKSPEEYL | 1811 | Q6ZTR5 | |
| PAPYFERSSSKRYTM | 426 | Q9Y2J2 | |
| LEMRTKSYPRYPLES | 586 | Q92613 | |
| EALYNQYMKEVGSPP | 166 | Q96EK5 | |
| YYMEKELANFDPSRP | 406 | Q86X29 | |
| PMDQKRYASSPYSDE | 1231 | P10586 | |
| SLPEDPKSSAYAMNY | 231 | Q12889 | |
| AESKMYATSPYSDPV | 1236 | P23468 | |
| MRDPLTDCPYNKVYK | 1 | Q8IVI9 | |
| YVYARPFTALPMDKA | 256 | Q8NGI6 | |
| YLDLQPSPFESKMSY | 321 | Q8N2Y8 | |
| RNLKAMDITGYSDPY | 386 | Q5T7P8 | |
| RMVALYDYDPRESSP | 956 | O15034 | |
| MSQYAPSPDFKRALD | 1 | B4DJY2 | |
| FYRSVDYNMPRSPVE | 1311 | O95425 | |
| KSMDQPEGTPVELYY | 216 | Q8N3T6 | |
| RDQMPPSYLLERYAK | 1601 | A0AVI2 | |
| KPPYSYIALIAMALA | 71 | Q13461 | |
| LPPTVISMKAQEYGY | 2211 | Q7Z333 | |
| LEAAVSPMDYPASYS | 526 | Q7Z7L1 | |
| GPMYQIYPRSFKDSN | 121 | Q07837 | |
| QYRASPPAESMSVYR | 1541 | Q9HCD6 | |
| DLPYAMKPIDYYTET | 161 | Q15738 | |
| YLLSNPEYKDTPMDI | 431 | Q8IXF0 | |
| YATLFFMYLRPPSKE | 251 | Q8NGP6 | |
| DRFMASNPSKVSYEP | 1876 | Q9NY46 | |
| PPASYTYKMDEVQNR | 226 | Q8NHU6 | |
| AYQLPADDYTSLMPV | 696 | Q9H6T0 | |
| SPQKEDRIPMADEYY | 546 | Q8NE31 | |
| SPTYSMAKRFAYPLD | 216 | Q8IXM7 | |
| RDMVYPYPGARAEEK | 1336 | Q99466 | |
| KYFLSVLADPYMPAE | 516 | Q8N122 | |
| MVPPYEYQTAKSRVL | 476 | Q9UK61 | |
| PPYIAMSSIDDYKNR | 1036 | O94911 | |
| IYYEPLEMTDPSKNL | 661 | Q9C0B6 | |
| YKYNPPDHDVVAMAR | 426 | P25440 | |
| GYMPYPSKSNQEVLE | 1326 | Q9UM73 | |
| EQTSKYPSRDMYRES | 851 | Q14865 | |
| LSMKPGEYSYFSPRT | 421 | Q15003 | |
| AYDPPVVMNADTLSY | 116 | Q8TBE1 | |
| DPPRYKCTEKSTYMN | 131 | Q9H5F2 | |
| YIEYGQQSRDPPVKM | 991 | A5YKK6 | |
| MSEVLPYGDEKLSPY | 1 | Q7Z7J9 | |
| KVYMDYNATTPLEPE | 31 | Q96I15 | |
| PALMYKPAVSDSLLY | 201 | Q6ZN11 | |
| DTIYPRNPAMYSEEA | 151 | P98170 | |
| DSKEYYMRLASGNPA | 2436 | Q8IZQ1 | |
| PELLMYTYSSGNKED | 66 | A0A0B4J271 | |
| LDLDSMAPPAYSLYT | 136 | Q8NDY8 | |
| KPVDPYSRMQSTYNY | 91 | O95793 | |
| SSPDMLYQYLKQIEP | 561 | Q9H6T3 | |
| IISAPDPSNRYYKMQ | 346 | O60687 | |
| ELYEKLPQGYRMEQP | 1061 | P35590 | |
| NSPPDYSEYMTGKKL | 246 | P25490 | |
| AALYAPKEPVLDYNM | 161 | Q8TCT7 | |
| RQKSTYTSYPKAEPM | 281 | O14964 | |
| ERFMASNPSKVSYEP | 1881 | Q99250 | |
| CQENKYRMDPPSEIY | 246 | Q5VUG0 | |
| RNPYVEAEYFPTKPM | 46 | Q8NEB5 | |
| ASAKLYMNPYAESEL | 301 | Q709C8 | |
| YMNPYAESELKTPKL | 306 | Q709C8 | |
| EAETMAEQGYRPKPY | 476 | Q9BT92 | |
| MSERKVLNKYYPPDF | 1 | Q9BW85 | |
| YDRKSDRPVYEGPSM | 1766 | P49750 | |
| YLMESECKAYNPRPF | 1946 | Q70CQ2 | |
| MPAPAATYERVVYKN | 1 | O95059 | |
| MDLYRYPSQDPLSKL | 1656 | Q6N021 | |
| ESLYPHTYNPKMSLD | 986 | Q92547 | |
| VYYKLTDGFMLPDPQ | 151 | Q8WW01 | |
| PFYDKPMRIQYAKTD | 76 | P09012 | |
| KDVGYPEFLNIRPYM | 341 | Q9P275 | |
| MGNYRRIYPPEDKAL | 451 | Q6ZT98 | |
| GYLYEDSPQPVTMEK | 166 | Q9NR11 | |
| TKPDVYKSPASDTYM | 106 | Q9BZK3 |